Tarbox Family Office, Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tarbox Family Office, Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,0000.0%220.0%0.00%
Q3 2021$1,0000.0%220.0%0.00%
Q2 2021$1,0000.0%220.0%0.00%
Q1 2021$1,0000.0%220.0%0.00%
Q4 2020$1,0000.0%220.0%0.00%
Q3 2020$1,0000.0%220.0%0.00%
Q2 2020$1,000
-50.0%
22
-56.0%
0.00%
-100.0%
Q1 2020$2,000
+100.0%
50
+78.6%
0.00%
Q4 2019$1,0000.0%28
+21.7%
0.00%
Q2 2019$1,000
-50.0%
230.0%0.00%
-100.0%
Q1 2019$2,000
+100.0%
230.0%0.00%
Q4 2018$1,0000.0%23
+43.8%
0.00%
Q3 2018$1,0000.0%160.0%0.00%
Q2 2018$1,0000.0%160.0%0.00%
Q1 2018$1,0000.0%160.0%0.00%
Q4 2017$1,0000.0%160.0%0.00%
Q3 2017$1,0000.0%160.0%0.00%
Q2 2017$1,0000.0%160.0%0.00%
-100.0%
Q1 2017$1,0000.0%160.0%0.00%0.0%
Q4 2016$1,0000.0%160.0%0.00%0.0%
Q3 2016$1,0000.0%160.0%0.00%0.0%
Q2 2016$1,0000.0%160.0%0.00%0.0%
Q1 2016$1,000160.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders